rs876657813
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_021167.5(GATAD1):c.249+2T>C variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021167.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATAD1 | ENST00000287957.5 | c.249+2T>C | splice_donor_variant, intron_variant | Intron 1 of 4 | 1 | NM_021167.5 | ENSP00000287957.3 | |||
GATAD1 | ENST00000644160.1 | n.105+2T>C | splice_donor_variant, intron_variant | Intron 1 of 1 | ||||||
GATAD1 | ENST00000645746.1 | n.249+2T>C | splice_donor_variant, intron_variant | Intron 1 of 5 | ENSP00000493785.1 | |||||
TMBIM7P | ENST00000641474.1 | n.-167A>G | upstream_gene_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The c.249+2T>C variant in GATAD1 has not been previously reported in individuals with cardiomyo pathy. Data from large population studies is insufficient to assess its frequenc y. This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or a bsent protein. The GATAD1 gene is associated with autosomal recessive DCM (Theis 2011) though the evidence is limited and the pathogenic variant spectrum is unk nown. In summary, although the c.249+2T>C variant is expected to have a severe i mpact on the protein, its clinical significance is uncertain. -
Dilated cardiomyopathy 2B Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in GATAD1 cause disease. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with GATAD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 228694). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change affects a donor splice site in intron 1 of the GATAD1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at